概述
Richard Spehr是Mayer Brown纽约办事处的管理合伙人。Rich是一位经验丰富的诉讼律师，入选“纽约州超级律师”榜单。他专注于复杂的商业诉讼，涉及联邦及州证券法、内部调查、美国证监会调查、美国司法部调查（包括《金融机构改革、复兴与实施法》（FIRREA）调查）、国际仲裁（国际商会国际仲裁院（ICC）、有效争议解决中心（CEDR）、伦敦国际仲裁院（LCIA）、联合国国际贸易法委员会）、衍生品、银行及金融服务。
Rich的客户包括美国国际集团（包括入选董事及高级管理人员诉讼律师库）、Ally Financial、安盛、美银、摩根士丹利、保诚保险、汇丰、葛兰素史克、默克药业及百时美施贵宝等。
Rich近期业绩及客户选摘如下：住宅抵押贷款支持证券（RMBS）诉讼（Ally/汇丰）、国际仲裁（先灵葆雅、百时美施贵宝）；放款人责任案（汇丰）；大宗商品交易案（雷曼兄弟）；外汇交易案（美银、中环集团）；证券诉讼（TV Azteca、Procom, Inc.、Collins & Aikman、ING Securities, Inc.、Twinlab Corporation，并代表众多发行人处理IPO造梯/股份分配案）、联邦及州消费者保护案（BMW）；衍生品案（BMO）；债券证券化案（美银）；欺诈性转让案（美银）；诉讼尽职调查（瑞士信贷第一波士顿）；困厄房产谈判（摩根士丹利）；不公平贸易行为案（Hampshire Equity Partners）；合并与收购（加拿大帝国商业银行）；证券诉讼（加拿大帝国商业银行）；并广泛代表发行人、公司董事及高级管理人员处理美国证监会及纽约州司法部发起的调查。
Rich于1994年加入Mayer Brown。在此之前，他在纽约一家知名律师行任职。
语言能力
- 英语
执业经验
- Represented international bank in FIRREA litigation and related civil cases.
- Represented several major banks in RMBS class action litigation.
- Represented a major pharmaceutical company in a highly significant AAA arbitration concerning a licensing dispute.
- Represented another major pharmaceutical company in an ICC arbitration in Paris over a patent maintenance dispute.
- Represented the former CFO of a major insurance company in multiple litigation matters and internal and government investigations emanating from the 2008 financial crisis.
- Represented several major global banks in financial crisis litigation stemming from the collapse of the subprime securitization market.
- Represented several leading pharmaceutical companies in litigations arising out of licensing, distribution, co-development and co-marketing agreements.
- Represented numerous issuers, and their officers and directors, in securities litigation matters.
- Represented a global bank in a lender liability case involving a failed real estate development.
- Represented a major European car manufacturer in several federal and state consumer protection investigations.
- Represented a health supplement manufacturer in a New York State Attorney General investigation.
- Represented several US investment banks in litigation arising out of mergers and acquisitions transactions.
- Led several major internal client investigations on behalf of the audit committee, officers and directors, and the company itself; handled governmental investigations.
- Represented a US pharmaceutical company in a governmental investigation arising out of New York’s False Claim Act.
- Represented a major insurance company in “life settlement” litigation.
- Represented debtors and creditors in various contested bankruptcy proceedings throughout the US.
- Represented an Asian pharmaceutical company in defamation action against a US short seller.
- Represented a major US data processing company in litigation over a licensing agreement.
- Represented an insurance company in class action TCPA litigation.
观点
-
3 月 12 日2020 年
相关活动
-
6 月 01 日2005
Expanding Duties and Liability: Corporate Directors in the Post-Enron Legal Environment
Washington Legal Foundation, Web Seminars Series
新闻
-
7 月 24 日2020 年
教育背景
State University of New York at Binghamton, 学士
St. John's University School of Law, JD
Editor, St. John's Law Review; St. Thomas More Scholar
执业资格
- 纽约州
出庭资格
- 美国第二巡回上诉法院
- 美国纽约州南区地方法院
- 美国纽约州东区地方法院